Loading...
Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study
Approximately 30% of patients with schizophrenia do not respond to antipsychotics and are thus considered to have treatment-resistant schizophrenia (TRS). To date, only four studies have examined glutamatergic neurometabolite levels using proton magnetic resonance spectroscopy ((1)H-MRS) in patients...
Na minha lista:
| Udgivet i: | Neuropsychopharmacology |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7021829/ https://ncbi.nlm.nih.gov/pubmed/31842203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-019-0589-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|